STERIS plc
STE
Latest Filing: May 29, 2026 • 25 Total Filings
Total Assets
2026
$10.74B
Total Revenue
2026
$5.94B
Net Income
2026
$782.30M
Operating Cash Flow
2026
$1.34B
Filing Year:
2026
Only 2026 data available
Data Source:
Showing data from all document types
Filters:
competes withcompetes withcompetes withcompetes withcompetes withcompetes withcompetes withcompetes withcompetes withcompetes withcompetes withcompetes withcompetes withcompetes withcompetes withcompetes withcompetes withcompetes withcompetes withcompetes withcompetes with
STERIS plc
Ticker: STE
3M
Major markets for packaging products
Ecolab
Pest and termite control services
Major Competitor
Fortive
Infection prevention and surgical supplies in MedSurg segment
Major Competitor
Baxter
Healthcare segment product competition
Boston Scientific
Healthcare segment product competition
Belimed
Healthcare segment product competition
Getinge
Healthcare segment product competition
Karl Storz
Healthcare segment product competition
Olympus
Healthcare segment product and service competition
Ruhof
Healthcare segment product competition
SteelCo
Healthcare segment product competition
Stryker
Healthcare segment product competition
Skytron
Healthcare segment product competition
Wassenburg
Healthcare segment product competition
BBraun
Healthcare segment service competition
Crothall
Healthcare segment service competition
Pentax
Healthcare segment service competition
Sterigenics
AST segment competition
Contec
Life Sciences segment competes with Contec in pharmaceutical and medical device products
Major Competitor
Fedegari
Life Sciences segment competes with Fedegari in pharmaceutical and medical device products
Major Competitor
Stilmas
Life Sciences segment competes with Stilmas in pharmaceutical and medical device products
Major Competitor
Legend:
Company
Critical Supplier
Significant Supplier
Standard Supplier
Major Competitor
Emerging Competitor
Competitor